Pharma Microbiology Testing Kits Market Outlook Indicates Strong Revenue And CAGR Growth Through 2030
How Much Growth Is Anticipated In The Pharma Microbiology Testing Kits Market Size From 2026 To 2035?
The pharma microbiology testing kits market size has grown strongly in recent years. It will grow from $7.26 billion in 2025 to $7.94 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to pharmaceutical quality regulations, biologics production growth, contamination risk awareness, vaccine manufacturing expansion, gmp compliance requirements.
The pharma microbiology testing kits market size is expected to see rapid growth in the next few years. It will grow to $11.98 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to biopharmaceutical pipeline growth, rapid testing technology adoption, regulatory stringency increase, contract manufacturing expansion, automation in quality control. Major trends in the forecast period include increased sterility testing frequency, rising adoption of rapid microbial detection, expansion of environmental monitoring programs, higher demand for ready-to-use test kits, outsourcing of microbiology testing services.
Claim Your Free Report Sample Today:
What Significant Demand Drivers Are Anticipated To Influence The Pharma Microbiology Testing Kits Market Over The Coming Years?
The growing prevalence of infectious diseases is expected to propel the growth of the pharma microbiology testing kits market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, that can be transmitted directly or indirectly from one individual to another. The rate of infectious disease incidence is rising due to increased travel, which facilitates the rapid spread of pathogens across borders. Pharma microbiology testing kits aid in infectious disease diagnosis by providing accurate and rapid detection of pathogens, making them essential for timely clinical decision-making. They improve laboratory efficiency by enabling reliable testing and supporting effective treatment and outbreak management. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the growing prevalence of infectious diseases is driving the growth of the pharma microbiology testing kits market.
What Segment Divisions Provide The Most Valuable Insights Into The Pharma Microbiology Testing Kits Market?
The pharma microbiology testing kits market covered in this report is segmented –
1) By Product: Consumables, Equipment
2) By Test: Endotoxin Testing, Sterility Testing, Microbial Examination, Environmental Monitoring, Other Tests
3) By End User: Hospitals And Diagnostic Centers, Custom Lab Service Providers, Academic And Research Institutes
Subsegments:
1) By Consumables: Media and Reagents, Test Kits, Sample Collection Containers
2) By Equipment: Incubators, Autoclaves, Microbial Identification Systems
Which Trends Are Reshaping Growth Within The Pharma Microbiology Testing Kits Market?
Major companies operating in the pharma microbiology testing kits market are focusing on the use of innovative technologies, such as artificial intelligence-powered software, to boost efficiency, enhance diagnostic accuracy, and streamline laboratory workflows. Artificial intelligence-powered software in this context refers to sophisticated algorithms that analyze complex data from diagnostic instruments to aid in the detection and identification of pathogens. For instance, in May 2023, Becton, Dickinson, and Company, a US-based medical device company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new BD Kiestra MRSA Imaging Application, which utilizes artificial intelligence (AI) to enhance the diagnosis of Methicillin-resistant Staphylococcus aureus (MRSA). The application automates the inspection of Petri dishes, traditionally a labor-intensive and time-consuming task. It analyzes bacterial growth on BBL CHROMagar MRSA II plates and can quickly identify specimens that show no significant growth, allowing for faster processing and release of negative results.
Who Are The Key Companies Actively Operating Within The Pharma Microbiology Testing Kits Market?
Major companies operating in the pharma microbiology testing kits market are F. Hoffmann-La Roche AG, Becton Dickinson and Company, Abbott Laboratories, ThermoFisher Scientific, SGS SA, Toxikon Corp., Pace Analytical Services, Boston Analytics, Charles River Laboratories International, Nelson Laboratories, Siemens healthcare AG, Hologic Inc., Neogen Corporation, Shimadzu Corporation, Merck KGaA, Agilent TechnologiesInc., QIAGEN N.V., Bruker Corporation, bioMérieux SA, Lucideon, Lonza Group AG, MilliporeSigma, Hardy Diagnostics, Sartorius AG, 3M Company, Waters Corporation, PerkinElmer Inc., Luminex Corporation
Get Your In-Depth Pharma Microbiology Testing Kits Market Report Now:
Which Regions Are Generating The Highest Demand Within The Pharma Microbiology Testing Kits Market?
North America was the largest region in the pharma microbiology testing kits market in 2025. Western Europe was the second-largest region in the global pharma microbiology testing kits market report. The regions covered in the pharma microbiology testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment